Skip to content
Nutrition & metabolismOverview of reviews4 min read

Ketogenic diets: firm evidence for lower triglycerides, fewer seizures, higher LDL

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials. · BMC medicine · 2023 · Original paper ↗

Key takeaway

In this review of 17 meta-analyses covering 68 trials, 51 of 115 associations (44%) were statistically significant, and only four were backed by high-quality evidence: lower triglycerides (2), fewer seizures (1) and higher LDL cholesterol (1). The trials were short (median follow-up 13 weeks) and small (median 42 participants), so long-term effects on heart events or survival remain unknown.

Study design

Overview of reviews

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Meta-analyses of randomized trials have reported benefits of ketogenic diets in conditions such as epilepsy and overweight or obesity, but nobody had graded the strength and quality of this evidence as a whole. The authors set out to rate the evidence on ketogenic diets and health outcomes across published meta-analyses.

Who and how

Umbrella review of meta-analyses of randomized clinical trials. PubMed, EMBASE, Epistemonikos and the Cochrane database of systematic reviews were searched up to February 15, 2023 for meta-analyses of ketogenic diets (KD), ketogenic low-carbohydrate high-fat diets (K-LCHF) and very low-calorie ketogenic diets (VLCKD). Meta-analyses were re-run with random-effects models, and the quality of evidence for each association was rated high, moderate, low or very low with the GRADE criteria.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    17 meta-analyses with 68 trials and 115 unique associations were included. The median sample size was 42 participants (IQR 20-104) and median follow-up 13 weeks (IQR 8-36). Of the 115 associations, 51 (44%) were statistically significant.
  2. 2
    Four associations had high-quality evidence: reduced triglycerides (2 associations) and seizure frequency (1), and increased LDL cholesterol (1). Four had moderate-quality evidence: decreases in body weight, respiratory exchange ratio and hemoglobin A1c, and increased total cholesterol. The rest had very low (26) to low (17) quality evidence.
  3. 3
    In adults with overweight or obesity, VLCKD was significantly associated with better body measurements and cardiometabolic outcomes without worsening muscle mass, LDL-C or total cholesterol.
  4. 4
    K-LCHF was associated with reduced body weight and body fat percentage, but also reduced muscle mass in healthy participants. The authors describe the LDL-C rise as clinically meaningful.

Limits & uncertainty

  1. 1
    The included trials were short and small (median 13 weeks, 42 participants), so the effects on heart attacks, strokes and death, which the authors say still need testing, are unknown.
  2. 2
    Most associations (26 very low, 17 low) had weak-quality evidence, so many significant results may not hold up.
  3. 3
    Results differ by diet type and population (VLCKD in overweight adults versus K-LCHF in healthy people) and an umbrella review cannot account for flaws inside the original trials.
  4. 4
    This reading is based on the abstract only.

What to take from it

A ketogenic diet reliably lowered triglycerides and seizure frequency in the best-graded evidence, and moved weight and blood sugar in a favorable direction, but it also raised LDL cholesterol and, in healthy people on K-LCHF, reduced muscle mass. Whether it is right for you, especially with epilepsy, diabetes or heart disease, is a decision to make with your clinician.

Reading your own data

If you follow a low-carbohydrate diet, a food log, regular weight, and a CGM or glucometer can show your own blood sugar response, while LDL cholesterol needs a laboratory blood test. Compare results taken under the same fasting conditions over months, not single readings.

How to read this evidence

Reviews may reuse the same trials. Review counts are not independent replications; study quality, overlap and outcome-specific certainty matter.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Systematic reviews and meta-analyses of randomized clinical trials (RCTs) have reported the benefits of ketogenic diets (KD) in various participants such as patients with epilepsy and adults with overweight or obesity. Nevertheless, there has been little synthesis of the strength and quality of this evidence in aggregate.

Methods

To grade the evidence from published meta-analyses of RCTs that assessed the association of KD, ketogenic low-carbohydrate high-fat diet (K-LCHF), and very low-calorie KD (VLCKD) with health outcomes, PubMed, EMBASE, Epistemonikos, and Cochrane database of systematic reviews were searched up to February 15, 2023. Meta-analyses of RCTs of KD were included. Meta-analyses were re-performed using a random-effects model. The quality of evidence per association provided in meta-analyses was rated by the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) criteria as high, moderate, low, and very low.

Results

We included 17 meta-analyses comprising 68 RCTs (median [interquartile range, IQR] sample size of 42 [20-104] participants and follow-up period of 13 [8-36] weeks) and 115 unique associations. There were 51 statistically significant associations (44%) of which four associations were supported by high-quality evidence (reduced triglyceride (n = 2), seizure frequency (n = 1) and increased low-density lipoprotein cholesterol (LDL-C) (n = 1)) and four associations supported by moderate-quality evidence (decrease in body weight, respiratory exchange ratio (RER), hemoglobin A_(1c), and increased total cholesterol). The remaining associations were supported by very low (26 associations) to low (17 associations) quality evidence. In overweight or obese adults, VLCKD was significantly associated with improvement in anthropometric and cardiometabolic outcomes without worsening muscle mass, LDL-C, and total cholesterol. K-LCHF was associated with reduced body weight and body fat percentage, but also reduced muscle mass in healthy participants.

Conclusions

This umbrella review found beneficial associations of KD supported by moderate to high-quality evidence on seizure and several cardiometabolic parameters. However, KD was associated with a clinically meaningful increase in LDL-C. Clinical trials with long-term follow-up are warranted to investigate whether the short-term effects of KD will translate to beneficial effects on clinical outcomes such as cardiovascular events and mortality.

Sources & attribution

Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials.

Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, Veettil SK, Chaiyakunapruk N.

BMC medicine · 2023-05-25

DOI: 10.1186/s12916-023-02874-y ↗PubMed · 37231411 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Early time-restricted eating linked to more weight loss and lower insulin than late eating

Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.

BMJ Medicine

In-depth explainersRead study →
·Randomised trial

An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss

Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.

The New England Journal of Medicine

In-depth explainersRead study →
·Randomised trial

In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain

In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.

Cell Metabolism

In-depth explainersRead study →
·Randomised trial

Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)

Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.

The New England Journal of Medicine

In-depth explainersRead study →
Nutrition & metabolism →